Vas 2006 (1)
of 123
/123
Embed Size (px)
description
Vas 2006 (1)
Transcript of Vas 2006 (1)
-
....
:
:
2006
-
, .
.
.
. ,
.
8
-
.................................................................................................................8
..................................................................................9
..........................................................................................................11
. ...................................................................................................12
..................................................................................................................1
1 ...................................................................3
1.1. ; .................................................................................................4
1.2. ............................................4
1.3. ...................................................................................8
1.4. ...................................................................10
1.5. ......................................................................................................10
1.6. / ............................................................11
1.7. : GATE CONTROL THEORY....14
1.8. ..............................................................................15
2 .................................................................18
2.1. ......................................................................................20
2.2. ..............................21
2.3. .......23
2.4. .........................................................................26
2.5. ...........................32
2.6. ..........................................................38
3 .......................................................................42
3.1. 43
3.2. ...................................45
3.3. ...........................46
3.4. ............................................58
3.5. ............................60
9
-
3.6. .................................................................................61
3.7. .................................................63
4
...............................................66
4.1. ...............................................68
4.2. ..........................................................................................70
4.3.
....................................................................................................................73
4.4. :
............................................74
. ...................................................................................................77
................................................................................................................78
..........................................79
......................................................................................................................................84
...................................................................................................86
- ....................................................................107
.....................................................................................................110
.......................................................................................................113
10
-
,
.
,
.
,
....
.
11
-
.
12
-
, ,
.
-
. IASP (International
Association for the Study of Pain, 1979)
.
, ,
. ,
,
. ,
.
.
.
,
.
,
.
(-)
,
.
,
.
,
, .
1
-
.
,
.
,
.
2
-
1
,
,
.
,
.
, , ,
, , , ,
.
, , , , , ,
, ,
(, 1999, . 9).
,
.
.
.
19 ,
.
30
: .
(, 1999, . 9).
3
-
, ,
,
.
.
,
, .
,
.
. :
.
, ,
, .
..
, .
1.1. ;
(International Association for the study of pain, 1979)
. ( , 1989).
1.2.
,
4
-
.
,
, ,
.
,
(, , , ,
, .).
.
,
.
50%
.
c
. , ,
( ) , , ( c)
.
C .
- . C
(.. , )
(, 1999, . 16).
5
-
,
.
, ,
.. ,
.
..
.
,
nociceptors, C
.
..
, , ,
.
(=).
.
( .. )
.
,
, ,
(, 1999)
(, , ).
6
-
,
,
... .
.
,
.
.
. C
,
.
, ,
.
(, 1999, .
19.)
, KCI, +, , , ,
, .
, .
,
.
7
-
. , ,
.
2
(.. ).
.
.
.
,
,
2.
2 .
(Stanley, 1989).
1.3.
,
.
Sherrington noxious=
.
, .
, .
/ (flexion withdrawal reflex,
).
,
.
8
-
innocuous stimuli,
,
,
.
. ,
,
. ,
, ,
(, 1999).
, .
. ,
:
.
,
.
.
.
. .
9
-
adequate stimulus= .
, .
1.4.
,
. .
, .
.
.
. (,
1999).
: -
:
- (sensory discriminative)
- (affective emotional)
(cognitive intercepte)
1.5.
1. : , , ,
C .
. ,
, .
2. . C
. .
, .
10
-
3. :
) :
) :
.
(
).
, ,
,
, (
).
,
(, ,
+ +, , ).
.
. .
.
.
,
(, 1999).
1.6. /
.
,
(McCaffery, 1999)
. ,
11
-
. , ,
: , ,
, ,
.
, ,
.
. ( / )
.
.
. /
. ..
.
.
. ,
. Lassagna
1960
.
.
( ) .
. . : , ,
, , . .
.
. . .
0 (= ) 10 ( ).
12
-
. .
.
. MPQ.
. .
. .
. .
, ,
.
, ,
.
.
,
.
. . ,
(
).
;
,
,
.
, ,
(),
. ,
,
.
, (..
, ...),
(Luban-plazza, 1998).
13
-
1.7. : GATE CONTROL THEORY
Metzack Wall 1965.
, C
.
,
,
C. C .
.
C , ,
. ,
.
,
.
. ,
C,
.
: .. ,
.
,
C, , ,
, .
.
,
C .
,
,
.
.
C
14
-
,
(McCaffery, 1999).
1.8.
,
. 3 6
,
.
.
.
(..
, ).
(, 1999, . 145-46).
1.
2. .
.
3.
, , , ,
. .
4. ,
, .
,
,
,
.
15
-
,
.
: (
)
,
, , ,
.
. ,
, ,
. ,
.
:
,
, .
.
1. ,
.
2. ,
, .
.
16
-
,
.
,
( . ,
, ).
placebo
.
.
placebo, .
placebo ,
, ,
, (, 1999, . 49).
17
-
2
.
,
.
.
.
( pain),
, ( 1).
, , ,
.
,
, .
, ,
, ,
.
2.1
18
-
. ,
,
.
,
.
, ,
,
. ,
, . ,
,
.
.
..
,
. ,
, .
,
.
.
, ,
, , ,
( ) ( ) .
.
. ,
,
19
-
. ,
. , ,
.
, , ,
(McCaffery, 1999).
2.1.
20
. .
, ,
.
, ,
.
, , ,
,
.
, ,
.
,
,
.
,
.
,
20
-
. ,
,
. ,
.
.
. ,
.
.
, .
.
,
. , ,
( , 1989, . 9-13).
2.2.
,
.
. ,
,
,
.
,
.
21
-
, ,
,
. ,
(..
),
, .
, .
.
,
.
, ,
.
: (1)
, . (2)
(.. ,
). (3) (..
, ). (4)
(.. , ).
.
, .
:(1)
, (2) , (3), , (4)
, (5) (6) (
).
,
( , 1989).
22
-
2.3.
: ,
.
.
, ,
,
.
.
.
(..., 1989, . 16, 17, 52).
1.
2.
,
,
.
,
.
, .
,
, , ,
, .
3.
,
, ,
23
-
,
.
25% .
, , .
.
4.
5.
,
.
6. .
. ,
,
,
. ,
, ,
.
,
.
.
7. .
, ,
, . ,
.
24
-
8. .
,
.
25
-
2.4.
_2.2
,
.
26
-
. ,
:
, .
.
.
2,
.
.
, .
,
, ,
. ,
.
,
. , (..., 1989,
. 19-21).
. ,
.
.
, , .
, , ,
,
. ,
, ,
27
-
.
,
,
. ,
.
, .
,
.
2.3
, .
.
28
-
, , , .
,
, .
, , .
, : (..., 1989, .
22-25).
1. .
.
, .
, .
. .
,
,
. ,
200mg 4 .
30mg .
2. .
.
,
.
,
.
, ,
29
-
. ,
,
.
3. .
.
,
,
.
4.
.
,
. ,
, ,
2/3 .
.
5.
.
,
, ,
.
. ,
, ,
.
6.
. ,
, ,
,
.
30
-
,
. ,
. .
,
.
,
.
.
.
,
.
,
.
.
.
, .
.
60-80%
.
, , .
,
31
-
.
. ,
, ,
.
2.5.
, ,
, ,
8-12 ,
, .
,
,
.
..
20-90
.
, ,
(, 1999, . 71).
( Hunter 1993)
(, 1997,
.3-8)/
1. :
)
32
-
.
. /
/
, ,
.
.
/
.
) / :
.
.
.
.
.
.
.
.
.
) .
33
-
25
.
.
/
.
30-50ml.
.
. ,
.
( )
.
.
P.C.A.
.
.
/ / .
, .
,
.
.
.
3-4 .
24.
34
-
.
2.
. .
.
,
.
3.
.
.
. Buprenorphine morphine
.
.
4.
.
.
.
() .
35
-
5.
patch
.
,
. Fentanyl
.
.
.
.
.
.
6.
.
7. / /
Karl Koller 1884
cocaine .
(lignocaine, bupivacaine prilocaine),
.
36
-
8.
EMLA. prilocaine lignocaine,
.
. Bupivacaine
.
.
9.
.
( bupivacaine).
.
10.
.
( )
.
(iliohypogastric)
(ilioinjunal) .
.
(
. )
.
37
-
.
.
11.
3 4 .
24 . (0,1-0,2mg).
. ,
.
.
.
2.6.
.
, . , ,
. ,
.
, .
, ,
, .
, ,
38
-
,
.
.
17 1975 1982.
.
.
, ,
. ,
,
. , ,
. ,
.
,
.
,
40.000 . 12.000 ,
,
4 ,
. ,
,
.
,
,
39
-
. ,
,
.
, ,
. , ,
.
, ,
. ,
,
,
.
,
,
. ,
. ,
,
,
. ,
,
,
.
. , ,
,
.
.
,
, .
,
,
.
40
-
.
. ,
/ ,
,
( ,
1989, . 34-36).
41
-
3
,
,
.
,
.
Lessing ,
,
. ,
.
,
, ,
, .
, ,
. ,
.
, .
;
;
; , ;
.
.
,
.
, ,
42
-
,
.
, .
.
.
, ,
... W. Loeffler
, ..
,
.
.
,
.
Velpeau, 1839
, ,
.
,
(, 1998, 169-171).
3.1.
(, 1999).
.
-
.
.
43
-
-
.
. ,
, .
.
-
.
.
.
- .
,
( ).
.
.
;
.
, ,
,
,
:
(, 1999).
1. , , ;
2. , ,
;
3.
(,
, , ...) ,
44
-
; ( , ,
;
;)
4. , ;
; , ,
;
5. ; ;
, ,
;
6. ;,
;
, ,
;
7. ,
;
3.2.
.
, ,
.
. , ,
.
.
,
.
.
45
-
,
, , .
.
,
. ,
, , , .
,
,
.
.
,
, ,
. , , ,
, .
.
.
.
, ,
,
.
.
,
.
.
(, 1986, . 42-43).
3.3.
,
46
-
( ).
(, 1986):
1
,
,
. ,
.
,
. , , ,
.
,
, ,
, .
.
, ,
.
,
( )
,
.
, .
,
.
47
-
:
.
.
() .
.
( , , ,
, ).
.
, .
)
,
, ,
,
. ,
,
. )
, ,
.
.
48
-
,
.
, ,
,
.
,
.
,
.
, .
, .
, .
.
, ,
. ,
,
. , ,
.
( )
, .
.
. ,
,
, .
49
-
,
, ,
, .
,
, .
:
.
. ,
.
,
.
.
.
,
.
,
.
. ,
.
, .
,
.
.
.
,
50
-
, ,
.
2
,
.
, ,
...
.
.
,
,
(
,
).
,
, ,
, .
.
.
.
,
51
-
,
.
,
. ,
.
.
,
. ,
. ,
, ,
, .
,
.
.
, ,
.
,
. ,
.
, , ,
.
,
. ,
, , ,
.
52
-
, , ,
, ,
.
3
,
.
,
. ,
.
,
.
.
, ,
.
, .
,
. ,
.
, ,
. ,
.
,
,
, .
53
-
Kubler Ross
.
, ,
( ) .
: .
,
.
,
.
,
. , ,
.
, .
( )
, ,
. ,
,
.
,
,
,
.
.
,
, .
54
-
.
: . , ,
: ,
,
, .
.
.
. , ,
, .
, ,
, .
.
, , ,
,
.
,
. ,
,
.
. ,
. , ,
,
. , ,
,
.
. ,
.
. .
,
55
-
, , ,
.
, ,
, .
.
, , .
.
, ,
, .
.
. ,
.
. ,
, ,
, , .
, , ,
. (
)
,
.
,
.
,
.
,
. ,
56
-
(.. )
.
, ,
,
.
.
.
,
.
. , ,
, ,
.
.
,
. , ,
.
.
, .
, .
.
.
.
, .
,
, .
57
-
.
, .
.
, , ,
, .
, .
.
,
.
,
,
,
.
,
(placebo effect). ,
,
(, 1986, . 48-51, 53-60).
3.4.
,
,
, ,
,
,
.
.
Baltrusch .
,
58
-
. ,
,
. ,
,
,
. ,
, . ,
,
.
, .
,
, , ,
.
.
, ,
, ,
, .
, ,
.
, , , ,
, ,
. ,
. stress
, , ,
, .
, . (
) , ,
59
-
.
,
, ,
. stress
,
(, 1986, . 62-63).
3.5.
.
,
,
(, , , ). ,
, , , , ,
,
, , .
,
.
,
, ,
.
,
.
. (2)
.
,
60
-
(, 1986, . 47).
3.6.
.
.
,
.
,
. Frankl (1987), ,
,
.
. ,
. ,
, .
(1986) ,
,
, ,
,
.
: ()
( ), ()
, .
.
61
-
Leshan(1981) Simonton
(1988), ,
,
. .. ,
.
.
, ..
...
. ,
(Wilson, 1989).
Whitehead (1989) -
.
, ,
. ,
, , , ,
, ,
.
Sachs (1992)
. , ..
,
...
, Wilson (1989),
62
-
, .
,
(, 1995, . 166-167).
3.7.
,
(Shakespeare, King Lear).
,
,
.
.
H. Plessner :
.
. , , .
, , , , , , ,
, , ,
! (, 1998, . 176-179).
,
, .
.
.. (J.H.Schultz)
.
.
,
.
.
,
:
63
-
. ..
,
.
.
.
. ,
,
.
.
,
,
.
,
, 16
, (, 1998):
, , ,
.
. , ,
,
.
,
.
,
, .
,
. ,
,
,
, ,
64
-
,
. ,
,
.
, ,
, ,
.
, ,
. (Montaigne, Essays).
65
-
4
,
.
,
,
90%.
25 ,
,
.
,
.
.
,
.
.
,
( , 2002,
. 29-30).
66
-
.
,
.
.
.
, ,
.
,
.
. ,
70%.
, , , , ,
... ( ,
2002).
.
(40 )
.
67
-
, (29 )
.
,
.
,
...
.
4.1.
,
. ,
.
.
, ,
.
,
.
, ,
.
(..., 1989, . 28-30):
, ,
.
68
-
,
,
.
.
, :
,
.
. ,
, .
.
, , , :
, ,
.
..
, ,
,
, ,
69
-
, ,
.
,
.
, ,
.
:
.
.
.
.
.
4.2.
(cancer unit)
(pain team),
, .
: ,
, , , , ,
.
70
-
, ,
, .
,
. , ,
.
,
(..., 1989).
,
. ,
,
. , , .
, ,
.
.
.
,
,
,
,
.
, ,
.
, ,
(, 1999).
71
-
. , ,
.
.
, ,
.
, . ,
,
, ,
(.. , ).
,
,
. ,
,
, .
,
.
.
.
, .
, ,
, (... 1989, .
37-39).
72
-
4.3.
. ,
, ,
,
.
,
, .
,
.
.
. ,
,
(..., 1989, .
14-15).
,
:
.
.
73
-
, , .
.
, ,
.
4.4. :
.
14 ...
( ,
2002).
305 ...
, 23
. 81%
2-15
.
14
,
.
, ,
.
...
(nurse specialist nurse practicioner),
.
74
-
.
,
,
,
.
.
,
, 46 .
Nurses Knowledge and Attitudes Survey Regarding Pain
.
McCaffery
.
.
Nurses
Knowledge and Attitudes Survey Regarding Pain 12
( , 2002).
.
51,5%
43,3% 74,6% 47,2%
.
, , , ,
.
75
-
,
. ,
,
,
,
.
.
,
,
.
,
.
Role Model Workshop
, 50 .
4 12 ,
12 (
, 2002).
76
-
.
77
-
. , ,
,
.
(...)
.
,
, ,
.
,
.
( )
.
78
-
,
, 85
,
. (Mc Millan SC , 2000)
.
. ,
,
. 82%
( ),
.
,
.
,
3 .
.
53 6
.
.
,
. (Howell D, 2000).
.
79
-
.
.
.
. ,
. (O'Brien S et all ,1996)
1400
.
24%.
.
Hollen
11 7
.
30 34 .
6 .
. (Hollen CJ et all. 2000)
,
.
.
.
.
80
-
. 44
303 . (Rushton P. 2003).
.
-
.
.
.
. .
350
. 10.9%.
.
. (Broekmans S (et all) 2004).
Cason CL
. (Cason
Cl (et all) 1999 ). 217 1 3,
(68%)
.
.
.
Hospital Palliative Care Team (Wells M et all,
2001 Sep)
,
.
81
-
.
135
,
Hospital Palliative Care Team.
.
,
.
.
.
-
,
(se MM et all, 2004).
, 1604
3 -
.
601 , 63 () 14
. 43%.
,
McCaffery & Ferrel,
. , ,
.
0,87
44%. ,
().
82
-
.
-.
,
(Dalton JA, 1989 Mar-Apr).
,
,
,
.
59 19 . 2
, ,
.
:
.
,
.
,
.
.
,
.
,
.
83
-
,
,
.
.
,
(Betty R. Ferrell, Margo McCaffery, 1987)
.
20 , 13
- 7
( ).
( ) .
(, , ).
200 , 100 .
32 (16%) 168 (84%).
124 (62%) 76 (38%)
. 34, 386,279
8,625,896 .
(=0,006).
(9,211,813) (8,441,817)
84
-
1
-
8,44
9,21
8
8,2
8,4
8,6
8,8
9
9,2
9,4
8,91 20
1,85.
.
1412108642
SCORE
50
40
30
20
10
0
Freq
uenc
y
Mean =8,91Std. Dev. =1,849
N =200
Histogram
, ,
,
.
85
-
.
Q1:
Q1
200 N / 0
95 47,5 47,5 47,5 105 52,5 52,5 100
200 100 100
Q1
60
50
40
30
20
10
0
Perc
ent
Q1
86
-
Q2:
Q2
200 N / 0
192 96 96 96 8 4 4 100
200 100 100
Q2
100
80
60
40
20
0
Perc
ent
Q2
2 (96%)
.
87
-
Q3:
Q3
200 N / 0
167 83,5 83,5 83,5 33 16,5 16,5 100
200 100 100
Q3
100
80
60
40
20
0
Perc
ent
Q3
3 83,5% ,
.
88
-
Q4: (.. metenamic acid-Ponstan) (.. mesulid),
Q4 200 N / 0
59 29,5 29,5 29,5 141 70,5 70,5 100
200 100 100
Q4
80
60
40
20
0
Perc
ent
Q4
89
-
Q5: (.. , , ...)
,
. Q5
200 N / 0
46 23 23 23 154 77 77 100
200 100 100
Q5
80
60
40
20
0
5 77%,
.
.
Perc
ent
Q5
90
-
Q6: (..
)
Q6
200 N / 0
88 44 44 44 112 56 56 100
200 100 100
Q6
60
50
40
30
20
10
0
Perc
ent
Q6
91
-
Q7: pethidine IM 4-5
Q7 200 N / 0
50 25 25 25 150 75 75 100
200 100 100
Q7
80
60
40
20
0
7 (75%)
Pethidine.
Perc
ent
Q7
92
-
Q8: (Phenergan) .
Q8
200 N / 0
135 67,5 67,5 67,5 65 32,5 32,5 100
200 100 100
Q8
60
40
20
0
Perc
ent
Q8
93
-
Q9:
Q9
200 N / 0
153 76,5 76,5 76,5 47 23,5 23,5 100
200 100 100
Q9
80
60
40
20
0
9 76,5%
.
Perc
ent
Q9
94
-
Q10: ,
200 N / 0
111 55,5 55,5 55,5 89 44,5 44,5 100
200 100 100
Q10
60
50
40
30
20
10
0
Perc
ent
Q10
95
-
Q11: , .
Q11
200 N / 0
66 33 33 33 134 67 67 100
200 100 100
Q11
60
40
20
0
Perc
ent
Q11
96
-
Q12: (placebo)
Q12
200 N / 0
53 26,5 26,5 26,5 147 73,5 73,5 100
200 100 100
Q12
80
60
40
20
0
Q13:
Perc
ent
Q12
97
-
Q13
200 N / 0
137 68,5 68,5 68,5 63 31,5 31,5 100
200 100 100
Q13
60
40
20
0
Perc
ent
Q13
98
-
Q14: :
Q14
200 N / 0
190 95 95 95 10 5 5 100
200 100 100
Q14
100
80
60
40
20
0
14 95%
.
( ,
,.)
Perc
ent
Q14
99
-
Q15: , (.. ) :
Q15
200 N / 0
138 69 69 69 62 31 31 100
200 100 100
Q15
60
40
20
0
Perc
ent
Q15
100
-
Q16: - :
Q16
200 N / 0
Q16
56 28 28 28 144 72 72 100
200 100 100
Q16
80
60
40
20
0
Perc
ent
Q16
101
-
Q17: :
Q17
200 N / 0
53 26,5 26,5 26,5 147 73,5 73,5 100
200 100 100
Q17
80
60
40
20
0
Perc
ent
Q17
102
-
Q18 :
Q18:
200 N / 0
99 49,5 49,5 49,5 101 50,5 50,5 100
200 100 100
Q18
60
50
40
30
20
10
0
Perc
ent
Q18
103
-
Q19: : 0%
Q19
200 N / 0
196 98 98 98 4 2 2 100
200 100 100
Q19
100
80
60
40
20
0
19 (98%)
.
.
Perc
ent
Q19
104
-
Q20:
:1-5%
Q20
200 N / 0
134 67 67 67 66 33 33 100
200 100 100
Q20
60
40
20
0
Perc
ent
Q20
105
-
.
..
1
/ Q1: 47% 58% 52,5% Q2:
3% 5% 4,0% Q3: 6% 27% 16,5% Q4: (.. metenamic acid-Ponstan) (.. mesulid), 74% 67% 70,5% Q5: (.. , , ...) , . 86% 68% 77,0% Q6: (.. ) 55% 57% 56,0% Q7: pethidine IM 4-5 73% 77% 75,0% Q8: (Phenergan) . 30% 35% 32,5% Q9: 25% 22% 23,5% Q10: , 40% 49% 44,5% Q11: , . 62% 72% 67,0% Q12: (placebo) 72% 75% 73,5%
Q13: 70% 33% 51,5% Q14: : 3% 7% 5,0% Q15: , (.. ) : 32% 30% 31,0% Q16: - : 76% 68% 72,0% Q17: : 79% 68% 73,5% Q18 : 54% 47% 50,5%
106
-
Q19: : 0% 0% 4% 2,0% Q20: :1-5% 29% 37% 33,0%
2
3% 5%
. 3
6%
27%. 5
86%
. 19 (0%)
(4%)
-
, ,
.
.
9,21
8,44 ,
.
8,91
20 .
107
-
.
.
:
.
,
.
,
.
.
,
.
, .
.
108
-
( ,
..)
.
. .
.
,
,
.
.
109
-
. ., , , , 1986.
., , , , 1999.
Luban pluzza, B. (..), , . , 1998.
. , , 1989.
., , university studio press, 1999.
. ., ,
2002, . 28.
., , , , , 1998.
., , , 1995.
Betty R. (et all). City of Hope. Nurses knowledge and attitudes
survey regarding pain, 1987
Broekmans S( et all). Nurses' attitudes toward pain treatment with opioids: a survey in a Belgian university hospital. Int J Nurs Stud. 2004
Feb;41(2):183-9.
Cason CL (et all). Nurses' knowledge of pain management: implications for staff education. J Nurses Staff Dev. 1999 Nov-Dec;15(6):228-
35.
Dalton JA.. Nurses' perceptions of their pain assessment skills, pain management practices, and attitudes toward pain. Oncol Nurs Forum.
1989 Mar-Apr;16(2):225-31
110
-
Ferrell, B. (et. al), The pain resource nurse training program, a unique approach to pain Management, us cancer pain relief committee,
publishes by elsevier, New York, 1993.
Ferrell, N. (et. al), Pain and addiction, an urgent need for change in nursing education us cancer pain relief committee, published be
elsevier, New York, 1992.
Fothergill-Bourbonnais F( et all). A comparative study of intensive therapy unit and hospice nurses' knowledge on pain management. J
Adv Nurs. 1992 Mar;17(3):362-72.
Hessig RE(et all). The effects of an educational intervention on oncology nurses' attitude, perceived knowledge, and self-reported application
of complementary therapies. Oncol Nurs Forum. 2004 Jan-Feb;31(1):71-8
Hollen CJ (et all). Hospice and hospital oncology unit nurses: a comparative survey of knowledge and attitudes about cancer pain. Oncol Nurs
Forum. 2000 Nov-Dec; 27(10):1593-9
Hollen CJ (et all). Hospice and hospital oncology unit nurses: a comparative survey of knowledge and attitudes about cancer pain. Oncol Nurs
Forum. 2000 Nov-Dec;27(10):1593-9
Howell D (et all). Influencing nurses' knowledge, attitudes, and practice in cancer pain management. Cancer Nurs. 2000 Feb;23(1):55-63
Mc Caffery M. (et. al), Connecting Misconceptions about pain assessment induce of opioid analgesics: educational strategies aimed at public
cancerous, nurse outlook, 1996, p.p.184-190.
Mc Caffery M., (et. al), Nurses personal opinions about patients pain their effect ion recorders assessments and titration of opioid
doses, pain management nursing, vol. 1, No3, September 2000, pp 79-87.
McMillan SC (et all). Knowledge and attitudes of nurses in veterans hospitals about pain management in patients with cancer. Oncol Nurs
Forum. 2000 Oct;27(9):1415-23
McMillan SC (et all). Training pain resource nurses: changes in their knowledge and attitudes. Oncol Nurs Forum. 2005 Jul 1;32(4):835-42
111
-
O'Brien S (et all). The knowledge and attitudes of experience oncology nurses regarding the management of cancer-related pain. Oncol Nurs
Forum. 1996 Apr;23(3):515-21
Rushton P (et all). Knowledge and attitudes about cancer pain management: a comparison of oncology and nononcology nurses. Oncol Nurs
Forum. 2003 Sep-Oct;30(5):849-55.
Schmidt K( et all). Pediatric cancer pain management: a survey of nurses' knowledge. J Pediatr Oncol Nurs. 1994 Jan;11(1):4-12; discussion
13
Stanley Kl Kirior R., , -. .
Tafas CA(et all) Testing an instrument measuring Greek nurses' knowledge and attitudes regarding pain . Cancer Nurs. 2002 Feb;25(1):8-14
Tse MM (et all). Knowledge and attitudes in pain management: Hong Kong nurses' perspective. J Pain Palliat Care Pharmacother.
2004;18(1):47-58
Vejlgaard T.(et all) Attitudes of Danish doctors and nurses to palliative and terminal care. Palliat Med. 2005 Mar;19(2):119-27.
Wells M( et all). The knowledge and attitudes of surgical staff towards the use of opioids in cancer pain management: can the Hospital
Palliative Care Team make a difference? Eur J Cancer Care (Engl). 2001
Sep;10(3):201-11.
:
http://www.springuet.com. Mccaffery, M. (et. al) opioids and pain Management.
www.geocities.com/iannisleo/pain. , , 1999.
112
-
(Betty R. (et all)., 1987)
/
1.
.
2. .
3. .
4. (.. metenamic acid-Ponstan)
(.. mesulid),
.
5. (.. , ,
...)
,
.
6.
(..
).
7. pethidine IM 4-5 .
113
-
8. (Phenergan)
.
9.
.
10.
, .
11. ,
.
12. (placebo)
.
13.
.
14.
:
.
.
.
.
.
.
15.
, (.. ) :
.
.
.
114
-
.
.
.
16. - :
.
.
.
.
17.
:
.
.
.
.
18.
:
.
.
.
.
19.
. [ ].
0 10 20 30 40 50 60 70 80 90
100%
20.
;
.
-
:
:
(, , )
!!!
116
-
117
. 1 1.1. ;1.2.
1.3.
1.4. 1.5. 1.6. / 1.7. : GATE CONTROL THEORY1.8.
2 2.1. 2.2. 2.3.
2.4.
2.5.
2.6.
3 3.1. 3.2. 3.3. 3.4. 3.5. 3.6. 3.7.
4 4.1.
4.2.
4.3. 4.4. :
. -
/ !!!
